The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Personalized protein coronas: a “key” factor at the nanobiointerface
Open accessAbstract
It is now well known that the primary interactions of biological entities (e.g., tissues and cells) with nanoparticles (NPs) are strongly influenced by the protein composition of the "corona" (i.e., the NP surface attached proteins). The composition of the corona strongly depends on the protein source (e.g., human plasma). Because the protein source determines the NP corona, it is reasonable to hypothesize that humans with specific disease(s) may have specific NP coronas. To test this hypothesis, we incubated two different hydrophobic/hydrophilic types of NPs (polystyrene and silica) with plasma from human subjects with different diseases and medical conditions (e.g., breast cancer, diabetes, hypercholesterolemia, rheumatism, fauvism, smoking, hemodialysis, thalassemia, hemophilia A and B, pregnancy, common cold and hypofibrinogenemia). Our results demonstrate that the type of disease has a crucial role in the protein composition of the NP corona. Based on these results, we introduce the concept of the "personalized protein corona" (PPC) as a determinant factor in nano-biomedical science. This study will help researchers rationally design experiments based on the "personalized protein corona" for clinical and biological applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Understanding biophysicochemical interactions at the nano–bio interface
Nel, A. E., Mädler, L., Velegol, D., Xia, T., Hoek, E. M. V., Somasundaran, P., Klaessig, F., Castranova, V., & Thompson, M. (2009) · Nature Materials · doi:10.1038/nmat2442 · Cited by 7,083
Anderson, N. L., & Anderson, N. G. (2002) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r200007-mcp200 · Cited by 4,414
Stress and disorders of the stress system
Chrousos, G. P. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.106 · Cited by 3,215
Biomolecular coronas provide the biological identity of nanosized materials
Monopoli, M. P., Åberg, C., Salvati, A., & Dawson, K. A. (2012) · Nature Nanotechnology · doi:10.1038/nnano.2012.207 · Cited by 3,017
Lundqvist, M., Stigler, J., Elia, G., Lynch, I., Cedervall, T., & Dawson, K. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805135105 · Cited by 2,823
Antibacterial properties of nanoparticles
Hajipour, M. J., Fromm, K. M., Akbar Ashkarran, A., Jimenez de Aberasturi, D., Larramendi, I. R. D., Rojo, T., Serpooshan, V., Parak, W. J., & Mahmoudi, M. (2012) · Trends in Biotechnology · doi:10.1016/j.tibtech.2012.06.004 · Cited by 2,710
Self-citationRapid formation of plasma protein corona critically affects nanoparticle pathophysiology
Tenzer, S., Docter, D., Kuharev, J., Musyanovych, A., Fetz, V., Hecht, R., Schlenk, F., Fischer, D., Kiouptsi, K., Reinhardt, C., et al. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2013.181 · Cited by 2,283
Mahmoudi, M., Sant, S., Wang, B., Laurent, S., & Sen, T. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.05.006 · Cited by 1,881
Self-citationMonopoli, M. P., Walczyk, D., Campbell, A., Elia, G., Lynch, I., Baldelli Bombelli, F., & Dawson, K. A. (2011) · Journal of the American Chemical Society · doi:10.1021/ja107583h · Cited by 1,835
Walkey, C. D., & Chan, W. C. W. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15233e · Cited by 1,758
Protein-nanoparticle interactions
Lynch, I., & Dawson, K. A. (2008) · Nano Today · doi:10.1016/s1748-0132(08)70014-8 · Cited by 1,727
Protein−Nanoparticle Interactions: Opportunities and Challenges
Mahmoudi, M., Lynch, I., Ejtehadi, M. R., Monopoli, M. P., Bombelli, F. B., & Laurent, S. (2011) · Chemical Reviews · doi:10.1021/cr100440g · Cited by 1,426
Self-citationThe molecular basis of blood coagulation
Furie, B., & Furie, B. C. (1988) · Cell · doi:10.1016/0092-8674(88)90567-3 · Cited by 1,247
What the Cell “Sees” in Bionanoscience
Walczyk, D., Bombelli, F. B., Monopoli, M. P., Lynch, I., & Dawson, K. A. (2010) · Journal of the American Chemical Society · doi:10.1021/ja910675v · Cited by 1,184
Tenzer, S., Docter, D., Rosfa, S., Wlodarski, A., Kuharev, J., Rekik, A., Knauer, S. K., Bantz, C., Nawroth, T., Bier, C., et al. (2011) · ACS Nano · doi:10.1021/nn201950e · Cited by 856
The Evolution of the Protein Corona around Nanoparticles: A Test Study
Lundqvist, M., Stigler, J., Cedervall, T., Berggård, T., Flanagan, M. B., Lynch, I., Elia, G., & Dawson, K. (2011) · ACS Nano · doi:10.1021/nn202458g · Cited by 752
Interactions of nanomaterials and biological systems: Implications to personalized nanomedicine
Zhang, X.-Q., Xu, X., Bertrand, N., Pridgen, E., Swami, A., & Farokhzad, O. C. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.08.005 · Cited by 487
The influence of protein adsorption on nanoparticle association with cultured endothelial cells
Ehrenberg, M. S., Friedman, A. E., Finkelstein, J. N., Oberdörster, G., & McGrath, J. L. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2008.09.050 · Cited by 412
Temperature: The “Ignored” Factor at the NanoBio Interface
Mahmoudi, M., Abdelmonem, A. M., Behzadi, S., Clement, J. H., Dutz, S., Ejtehadi, M. R., Hartmann, R., Kantner, K., Linne, U., Maffre, P., et al. (2013) · ACS Nano · doi:10.1021/nn305337c · Cited by 333
Self-citationRare inherited disorders of fibrinogen
ACHARYA, S. S., & DIMICHELE, D. M. (2008) · Haemophilia · doi:10.1111/j.1365-2516.2008.01831.x · Cited by 238
Krol, S., Macrez, R., Docagne, F., Defer, G., Laurent, S., Rahman, M., Hajipour, M. J., Kehoe, P. G., & Mahmoudi, M. (2013) · Chemical Reviews · doi:10.1021/cr200472g · Cited by 216
Self-citationInhibitors of Factor VIII in Black Patients with Hemophilia
Viel, K. R., Ameri, A., Abshire, T. C., Iyer, R. V., Watts, R. G., Lutcher, C., Channell, C., Cole, S. A., Fernstrom, K. M., Nakaya, S., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa075760 · Cited by 197
Engström, G., Lind, P., Hedblad, B., Stavenow, L., Janzon, L., & Lindgärde, F. (2002) · Circulation · doi:10.1161/01.cir.0000017327.69909.ff · Cited by 194
Investigating diversity in human plasma proteins
Nedelkov, D., Kiernan, U. A., Niederkofler, E. E., Tubbs, K. A., & Nelson, R. W. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500426102 · Cited by 192
Plasma Apolipoproteins AI, AII, B, CI, and E Are Glucosylated in Hyperglycemic Diabetic Subjects
Curtiss, L. K., & Witztum, J. L. (1985) · Diabetes · doi:10.2337/diab.34.5.452 · Cited by 189
Proteomic analysis of high‐density lipoprotein
Rezaee, F., Casetta, B., Levels, J. H. M., Speijer, D., & Meijers, J. C. M. (2006) · PROTEOMICS · doi:10.1002/pmic.200500191 · Cited by 174
Self-citationMahmoudi, M., Sahraian, M. A., Shokrgozar, M. A., & Laurent, S. (2011) · ACS Chemical Neuroscience · doi:10.1021/cn100100e · Cited by 172
Self-citationA Phospholipidomic Analysis of All Defined Human Plasma Lipoproteins
Dashty, M., Kulik, W., Hoek, F. J., Veerman, E. C. I., Peppelenbosch, M. P., & Rezaee, F. (2011) · Scientific Reports · doi:10.1038/srep00139 · Cited by 134
Self-citationDashty, M., Motazacker, M. M., Levels, J. H. M., de Vries, M., Mahmoudi, M., Peppelenbosch, M. P., & Rezaee, F. (2014) · Thrombosis and Haemostasis · doi:10.1160/th13-02-0178 · Cited by 130
Self-citationProtein oxidation biomarkers in plasma of type 2 diabetic patients
Pandey, K. B., Mishra, N., & Rizvi, S. I. (2009) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2009.11.011 · Cited by 129
Haemophilia A and haemophilia B: molecular insights
Bowen, D. J. (2002) · Molecular Pathology · doi:10.1136/mp.55.1.1 · Cited by 98
Conformation and orientation of a protein folding intermediate trapped by adsorption
Engel, M. F. M., Visser, A. J. W. G., & van Mierlo, C. P. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401603101 · Cited by 95
Significance of cell “observer” and protein source in nanobiosciences
Laurent, S., Burtéa, C., Thirifays, C., Rezaee, F., & Mahmoudi, M. (2012) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2012.10.005 · Cited by 75
Self-citationPlasma concentration gradient influences the protein corona decoration on nanoparticles
Ghavami, M., Saffar, S., Emami, B. A., Peirovi, A., Shokrgozar, M. A., Serpooshan, V., & Mahmoudi, M. (2012) · RSC Advances · doi:10.1039/c2ra22093h · Cited by 74
Self-citationHard corona composition and cellular toxicities of the graphene sheets
Mao, H., Chen, W., Laurent, S., Thirifays, C., Burtéa, C., Rezaee, F., & Mahmoudi, M. (2013) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2013.03.049 · Cited by 73
Self-citationSlight temperature changes affect protein affinity and cellular uptake/toxicity of nanoparticles
Mahmoudi, M., Shokrgozar, M. A., & Behzadi, S. (2013) · Nanoscale · doi:10.1039/c3nr32551b · Cited by 65
Self-citationNonenzymatic Glycosylation of Serum and Plasma Proteins
Kennedy, L., Mehl, T. D., Elder, E., Varghese, M., & Merimee, T. J. (1982) · Diabetes · doi:10.2337/diab.31.3.s52 · Cited by 54
Human Plasma Very Low Density Lipoprotein Carries Indian Hedgehog
Queiroz, K. C. S., Tio, R. A., Zeebregts, C. J., Bijlsma, M. F., Zijlstra, F., Badlou, B. A., de Vries, M., Ferreira, C. V., Spek, C. A., Peppelenbosch, M. P., et al. (2010) · Journal of Proteome Research · doi:10.1021/pr100403q · Cited by 53
Self-citationLaurent, S., Ng, E., Thirifays, C., Lakiss, L., Goupil, G.-M., Mintova, S., Burtéa, C., Oveisi, E., Hébert, C., de Vries, M., et al. (2013) · Toxicology Research · doi:10.1039/c3tx50023c · Cited by 51
Self-citationSmoking, COPD, and 3-Nitrotyrosine Levels of Plasma Proteins
Jin, H., Webb‐Robertson, B., Peterson, E., Tan, R., Bigelow, D. J., Scholand, M. B., Hoidal, J. R., Pounds, J. G., & Zangar, R. C. (2011) · Environmental Health Perspectives · doi:10.1289/ehp.1103745 · Cited by 44
Plasma Proteome Profiles Associated with Inflammation, Angiogenesis, and Cancer
Kelly‐Spratt, K. S., Pitteri, S. J., Gurley, K. E., Liggitt, D., Chin, A. P., Kennedy, J. J., Wong, C., Zhang, Q. H., Buson, T. B., Wang, H., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019721 · Cited by 43
Proteomic Study of Plasma from Moderate Hypercholesterolemic Patients
Alonso‐Orgaz, S., Moreno, L., Macaya, C., Rico, L., Mateos‐Cáceres, P. J., Sacristán, D., Pérez‐Vizcaíno, F., Segura, A., Tamargo, J. L., & López-Farré, A. J. (2006) · Journal of Proteome Research · doi:10.1021/pr060159w · Cited by 43
Characterization of coagulation factor synthesis in nine human primary cell types
Dashty, M., Akbarkhanzadeh, V., Zeebregts, C. J., Spek, C. A., Sijbrands, E. J. G., Peppelenbosch, M. P., & Rezaee, F. (2012) · Scientific Reports · doi:10.1038/srep00787 · Cited by 40
Self-citationA Novel Transgenic Mouse Model of Hyperfibrinogenemia
Gulledge, A. A., Rezaee, F., Verheijen, J. H., & Lord, S. T. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1616079 · Cited by 37
Self-citationPlasma Protein Characteristics of Long-Term Hemodialysis Survivors
Lin, Y., Yang, C., Liao, C.-C., Yu, W., Chi, C., & Lin, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040232 · Cited by 25
Riley, C. P., Zhang, X., Nakshatri, H., Schneider, B. P., Regnier, F. E., Adamec, J., & Buck, C. R. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-80 · Cited by 17
Fibrinogen and atherosclerosis: a study in transgenic mice
Koopman, J., Maas, A. C. E., Rezaee, F., Havekes, L. M., Verheijen, J. H., Gijbels, M. J., & Haverkate, F. (1997) · Fibrinolysis and Proteolysis · doi:10.1016/s0268-9499(97)80016-1 · Cited by 11
Self-citationRezaee, F., Maas, A. C. E., de Maat, M. P. M., Verheijen, J. H., & Koopman, J. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(02)00044-8 · Cited by 11
Self-citationPlasma and Serum Proteins in Chronic Rheumatic Diseases
Salt, H. B. (1951) · Annals of the Rheumatic Diseases · doi:10.1136/ard.10.1.46 · Cited by 11
Chu, N.-F., Chang, J.-B., & Shieh, S.-M. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802274 · Cited by 9
Protein fibrillation and the olfactory system: speculations on their linkage
Mahmoudi, M., & Suslick, K. S. (2012) · Trends in biotechnology · doi:10.1016/j.tibtech.2012.08.007 · Cited by 4
Self-citation
Cited by
Cancer nanomedicine: progress, challenges and opportunities
Shi, J., Kantoff, P. W., Wooster, R., & Farokhzad, O. C. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.108 · Cited by 5,873
Cellular uptake of nanoparticles: Journey inside the cell
Behzadi, S., Serpooshan, V., Tao, W., Hamaly, M. A., Alkawareek, M. Y., Dreaden, E. C., Brown, D., Alkilany, A. M., Farokhzad, O. C., & Mahmoudi, M. (2017) · Chemical Society Reviews · doi:10.1039/c6cs00636a · Cited by 2,859
Self-citationThe Impact of Nanoparticle Protein Corona on Cytotoxicity, Immunotoxicity and Target Drug Delivery
Corbo, C., Molinaro, R., Parodi, A., Toledano Furman, N. E., Salvatore, F., & Tasciotti, E. (2016) · Nanomedicine · doi:10.2217/nnm.15.188 · Cited by 692
Protein corona: a new approach for nanomedicine design
Nguyen, V. H., & Lee, B.-J. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s129300 · Cited by 638
The protein corona from nanomedicine to environmental science
Mahmoudi, M., Landry, M. P., Moore, A., & Coreas, R. (2023) · Nature Reviews Materials · doi:10.1038/s41578-023-00552-2 · Cited by 625
Self-citation
Metadata
- Authors
- Hajipour, M. J., Laurent, S., Aghaie, A., Rezaee, F., & Mahmoudi, M.
- Venue
- Biomaterials Science
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2014-05-30
- Volume
- 2
- Issue
- 9
- Pages
- 1210
- ISSN
- 2047-4830 (ISSN-L)
- 2047-4849
- OpenAlex
- W2023202045
- Cited by
- 307
- References
- 51
- FWCI
- 9.10
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.